When a fully funded company like PRR is in FDA Phase IIa/b trials for its cancer drug its market cap will approach US$500m to $1billion depending on the size of the commercial market for its drug. For PRR that market size is greater than US$3.8b.
In Phase III it may actually head over the magic Billion and then when FDA approved double or more to $2 Billion. or fall away if not approved. Non approval is still 12 months away...so value should be migrating into PRR.
Denenron is a US$4billion company and was a $1 billion company at Phase 11b. Similar for Imclone which was bought by Eli Lilly.
So the comparable Price based on market cap attribution of PRR right now should be 50c to $1.00 so im very happy owning at these levels
Good Luck !
the real value of prr
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |